Literature DB >> 24518299

Comprehensive tracking of host cell proteins during monoclonal antibody purifications using mass spectrometry.

Qingchun Zhang1, Andrew M Goetze1, Huanchun Cui2, Jenna Wylie2, Steve Trimble3, Art Hewig2, Gregory C Flynn1.   

Abstract

An advanced two-dimensional liquid chromatography/mass spectrometry platform was used to quantify individual host cell proteins (HCPs) present at various purification steps for several therapeutic monoclonal antibodies (mAbs) produced in Chinese hamster ovary cells. The methodology produced reproducible identifications and quantifications among replicate analyses consistent with a previously documented individual limit of quantification of ~13 ppm. We were able to track individual HCPs from cell culture fluid to protein A eluate pool to subsequent viral inactivation pool and, in some cases, further downstream. Approximately 500 HCPs were confidently identified in cell culture fluid and this number declined progressively through the purification scheme until no HCPs could be confidently identified in polishing step cation-exchange eluate pools. The protein A eluate pool of nine different mAbs contained widely differing numbers, and total levels, of HCPs, yet the bulk of the total HCP content in each case consisted of a small subset of normally intracellular HCPs highly abundant in cell culture fluid. These observations hint that minimizing cell lysis during cell culture/harvest may be useful in minimizing downstream HCP content. Clusterin and actin are abundant in the protein A eluate pools of most mAbs studied. HCP profiling by this methodology can provide useful information to process developers and lead to the refinement of existing purification platforms.

Entities:  

Keywords:  Host cell proteins; antibody; mass spectrometry; monoclonal

Mesh:

Substances:

Year:  2014        PMID: 24518299      PMCID: PMC4011910          DOI: 10.4161/mabs.28120

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  37 in total

Review 1.  Similar biological medicinal products containing recombinant human growth hormone: European regulation.

Authors:  Mira Pavlovic; Elizabeth Girardin; Liliana Kapetanovic; Kowid Ho; Jean-Hugues Trouvin
Journal:  Horm Res       Date:  2007-12-04

2.  Host cell protein clearance during protein A chromatography: development of an improved column wash step.

Authors:  Abhinav A Shukla; Peter Hinckley
Journal:  Biotechnol Prog       Date:  2008 Sep-Oct

3.  Proteomic profiling of CHO cells with enhanced rhBMP-2 productivity following co-expression of PACEsol.

Authors:  Paula Meleady; Michael Henry; Patrick Gammell; Padraig Doolan; Martin Sinacore; Mark Melville; Linda Francullo; Mark Leonard; Timothy Charlebois; Martin Clynes
Journal:  Proteomics       Date:  2008-07       Impact factor: 3.984

4.  European Medicines Agency workshop on biosimilar monoclonal antibodies: July 2, 2009, London, UK.

Authors:  Janice M Reichert; Alain Beck; Harish Iyer
Journal:  MAbs       Date:  2009-09-25       Impact factor: 5.857

5.  Design of therapeutic proteins with enhanced stability.

Authors:  Naresh Chennamsetty; Vladimir Voynov; Veysel Kayser; Bernhard Helk; Bernhardt L Trout
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

6.  Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): Implications for downstream process development.

Authors:  Mi Jin; Nicolas Szapiel; Jennifer Zhang; John Hickey; Sanchayita Ghose
Journal:  Biotechnol Bioeng       Date:  2010-02-01       Impact factor: 4.530

7.  Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity.

Authors:  Sharon X Gao; Ying Zhang; Kensey Stansberry-Perkins; Alex Buko; Shujun Bai; Vanessa Nguyen; Mark L Brader
Journal:  Biotechnol Bioeng       Date:  2010-11-17       Impact factor: 4.530

Review 8.  Actin structure and function.

Authors:  Roberto Dominguez; Kenneth C Holmes
Journal:  Annu Rev Biophys       Date:  2011       Impact factor: 12.981

9.  Proteomic profiling of a high-producing Chinese hamster ovary cell culture.

Authors:  Tyler Carlage; Marina Hincapie; Li Zang; Yelena Lyubarskaya; Helena Madden; Rohin Mhatre; William S Hancock
Journal:  Anal Chem       Date:  2009-09-01       Impact factor: 6.986

10.  The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS.

Authors:  Scott J Geromanos; Johannes P C Vissers; Jeffrey C Silva; Craig A Dorschel; Guo-Zhong Li; Marc V Gorenstein; Robert H Bateman; James I Langridge
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

View more
  15 in total

1.  Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis.

Authors:  James A Madsen; Victor Farutin; Theresa Carbeau; Steve Wudyka; Yan Yin; Stephen Smith; James Anderson; Ishan Capila
Journal:  MAbs       Date:  2015-08-20       Impact factor: 5.857

2.  A modular and adaptive mass spectrometry-based platform for support of bioprocess development toward optimal host cell protein clearance.

Authors:  Donald E Walker; Feng Yang; Joseph Carver; Koman Joe; David A Michels; X Christopher Yu
Journal:  MAbs       Date:  2017-03-27       Impact factor: 5.857

3.  Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics.

Authors:  Vibha Jawa; Marisa K Joubert; Qingchun Zhang; Meghana Deshpande; Suminda Hapuarachchi; Michael P Hall; Gregory C Flynn
Journal:  AAPS J       Date:  2016-07-22       Impact factor: 4.009

Review 4.  Process- and Product-Related Foulants in Virus Filtration.

Authors:  Solomon Isu; Xianghong Qian; Andrew L Zydney; S Ranil Wickramasinghe
Journal:  Bioengineering (Basel)       Date:  2022-04-04

5.  A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies.

Authors:  Nabila Aboulaich; Wai Keen Chung; Jenny Heidbrink Thompson; Christopher Larkin; David Robbins; Min Zhu
Journal:  Biotechnol Prog       Date:  2014-07-26

Review 6.  The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.

Authors:  Daniel G Bracewell; Richard Francis; C Mark Smales
Journal:  Biotechnol Bioeng       Date:  2015-07-14       Impact factor: 4.530

7.  ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.

Authors:  Scott M Henry; Elissa Sutlief; Oscar Salas-Solano; John Valliere-Douglass
Journal:  MAbs       Date:  2017-07-14       Impact factor: 5.857

8.  Quantitative definition and monitoring of the host cell protein proteome using iTRAQ - a study of an industrial mAb producing CHO-S cell line.

Authors:  Lesley M Chiverton; Caroline Evans; Jagroop Pandhal; Andrew R Landels; Byron J Rees; Peter R Levison; Phillip C Wright; C Mark Smales
Journal:  Biotechnol J       Date:  2016-06-22       Impact factor: 4.677

9.  Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.

Authors:  Cher Hui Goey; David Bell; Cleo Kontoravdi
Journal:  MAbs       Date:  2018-02-16       Impact factor: 5.857

10.  Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab.

Authors:  Neungseon Seo; Alla Polozova; Mingxuan Zhang; Zachary Yates; Shawn Cao; Huimin Li; Scott Kuhns; Gwendolyn Maher; Helen J McBride; Jennifer Liu
Journal:  MAbs       Date:  2018-04-20       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.